Ixekizumab versus adalimumab for active psoriatic arthritis

被引：0
|
作者：
Thorley, Jennifer
机构：
来源：
LANCET RHEUMATOLOGY | 2019年 / 1卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E143 / E143
页数：1
相关论文
共 50 条
  • [1] Secukinumab versus adalimumab for psoriatic arthritis
    Thorley, Jennifer
    LANCET RHEUMATOLOGY, 2020, 2 (06): : E322 - E322
  • [2] lxekizumab versus adalimumab for psoriatic arthritis
    Thorley, Jennifer
    LANCET RHEUMATOLOGY, 2020, 2 (09): : E526 - E526
  • [3] SAFETY PROFILES OF IXEKIZUMAB VERSUS ADALIMUMAB: 52-WEEK RESULTS FROM A HEAD-TO-HEAD COMPARISON IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS
    Mease, P. J.
    Smolen, J. S.
    Kavanaugh, A.
    Nash, P.
    Gallo, G.
    Leage, S. Liu
    Sapin, C.
    Genovese, M. C.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1698 - 1698
  • [4] Safety Profiles of Ixekizumab versus Adalimumab: 52-Week Results from a Head-to-Head Comparison in Patients with Active Psoriatic Arthritis
    Mease, Philip
    Smolen, Josef
    Kavanaugh, Arthur
    Nash, Peter
    Gallo, Gaia
    Liu-Leage, Soyi
    Sapin, Christophe
    Genovese, Mark
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [5] Safety Profiles of Ixekizumab versus Adalimumab: 52-Week Results from a Head-to-Head Comparison in Patients With Active Psoriatic Arthritis
    Mease, Philip
    Smolen, Josef
    Kavanaugh, Arthur
    Nash, Peter
    Gallo, Gaia
    Liu-Leage, Soyi
    Sapin, Christophe
    Genovese, Mark
    Bessette, Louis
    JOURNAL OF RHEUMATOLOGY, 2021, 48 (07) : 1167 - 1167
  • [6] Tofacitinib or Adalimumab versus Placebo for Psoriatic Arthritis
    Mease, P.
    Hall, S.
    FitzGerald, O.
    van der Heijde, D.
    Merola, J. F.
    Avila-Zapata, F.
    Cieslak, D.
    Graham, D.
    Wang, C.
    Menon, S.
    Hendrikx, T.
    Kanik, K. S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (16): : 1537 - 1550
  • [7] COST PER RESPONDER OF APREMILAST VERSUS ETANERCEPT AND ADALIMUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS
    Tencer, T.
    Clancy, Z.
    Zhang, F.
    VALUE IN HEALTH, 2014, 17 (07) : A376 - A376
  • [8] Ixekizumab in the treatment of psoriatic arthritis
    Lespessailles, Eric
    Toumi, Hechmi
    IMMUNOTHERAPY, 2021, 13 (01) : 19 - 33
  • [9] Adalimumab in Psoriatic Arthritis
    Salvarani, Carlo
    Pipitone, Nicolo
    Catanoso, Mariagrazia
    Chiarolanza, Ilaria
    Boiardi, Luigi
    Caruso, Andrea
    Pazzola, Giulia
    Macchioni, Pierluigi
    Di Lernia, Vito
    Albertini, Giuseppe
    JOURNAL OF RHEUMATOLOGY, 2012, 39 : 77 - 81
  • [10] INDIRECT COMPARISON OF ADALIMUMAB VERSUS ETANERCEPT FOR THE TREATMENT OF PSORIATIC ARTHRITIS
    Kirson, N.
    Rao, S.
    Birnbaum, H. G.
    Kantor, E.
    Wei, R.
    Cifaldi, M.
    VALUE IN HEALTH, 2011, 14 (03) : A129 - A130
12345